SUMMARY The association of diaphyseal aclasis and neurofibromatosis with malignant neoplasms has been variously reported as between 5 and 28 % of all cases, but malignant disease invariably presents at hospital and the true frequency from an unselected group is unknown. The current survey reviews not only hospital patients but also their affected relatives, with particular reference to malignant disease and the cause of death in all family members. A survey of 36 index patients and 80 known affected relatives with diaphyseal aclasis and 37 index patients and 33 known affected relatives with neurofibromatosis has been carried out. The observed proportions with associated malignant disease were 0 9 % of all cases of diaphyseal aclasis and 4-3 % of neurofibromatosis. The authors consider this is still too high an estimate in view of the number of persons in the families only mildly affected by the inherited disease who cannot be identified, although their malignant disease will be known. A more likely figure for malignant change in diaphyseal aclasis is calculated at 0 5 % (or 1-3 % of those over 21 years) and in neurofibromatosis 2f0 % (or 4 f2 % of those over 21 years).
Diaphyseal aclasis and neurofibromatosis are both developmental disorders of autosomal dominant inheritance, the former affecting the skeleton and the latter principally the supportive tissues of the nervous system, although bony pathology also occurs.
Their association with malignant neoplasms is well known, the frequency being variously recorded as between 5 and 28 % of all cases,'-7 but patients with malignant disease inevitably present at hospital and are frequently selected for reporting.
The current survey differs from previous reports in aiming to review not only hospital patients with diaphyseal aclasis and neurofibromatosis, but also their relatives, with particular reference to malignant disease and the cause of death in all family members, not only those known to be affected with the inherited disorder. Diaphyseal aclasis is one of the commoner skeletal dysplasias, with an estimated prevalence in the population of about 9 per 1 000 000 (WynneDavies and Gormley, unpublished data, 1981). It is characterised by multiple exostoses limited to enchondral bone, usually arising in the juxtaepiphyseal region of the long bones but also Received for publication 25 January 1983.
Accepted for publication 3 February 1983. frequently present in the pelvis, scapula, and ribs. The age of onset (or diagnosis) varies from birth to adult life, but over 80 % are diagnosed during the first decade. 8 The infrequency ofmalignant disease in diaphyseal aclasis and neurofibromatosis too high an estimate, in view of the likely numbers of subjects only mildly affected by the inherited disease who cannot be identified, whereas those with malignant change will almost certainly be known. Calculating the theoretical maximum and minimum of affected subjects in the population studied and taking the mid-point, a more likely figure for diaphyseal aclasis is 0 5 % and for neurofibromatosis 2. 0 % of all cases. Since malignant change is unusual in childhood, a more clinically useful estimate is the proportion of those over 21 years developing malignant disease, which is 1 
